This article discusses the role of the FAD-dependent lysine specific demethylase, KDM1, in brain function, and consequently its potential use as a target for treatments for neurodegenerative disease.
New research has presented an innovative imaging technology that could reduce the risk associated with brain tumor removal by providing surgeons with a color-coded map of a patient’s brain.
A new method for classifying low and intermediate grade gliomas has recently been reported in the in the New England Journal of Medicine. This new approach could lead to improvements in diagnosis, treatment and potentially patient outcomes.
This management perspective discusses the role of multidisciplinary clinics, in an attempt to create preliminary guidelines on establishing and maintaining a multidisciplinary brain tumor clinic in order to optimize the care of the patients and their families.
This case report is the first report of the safety and tolerability of intrathecal rituximab in an indolent CNS lymphoma.
In this exclusive webinar, Oncology Central Ambassador Arjun Sahgal from Sunnybrook Health Sciences Centre (ON, Canada) discusses future directions of…
Aims: This retrospective study determined the survival of glioblastoma patients with or without pseudoprogression. Methods: A total of 68 patients…